These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6549500

  • 1. Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan.
    Motycka K, Chudomel V, Bednár M, Bostík J.
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):413-9. PubMed ID: 6549500
    [Abstract] [Full Text] [Related]

  • 2. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
    Motycka K, Chudomel V, Bednár M, Bostík J.
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):405-12. PubMed ID: 6549499
    [Abstract] [Full Text] [Related]

  • 3. The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative.
    Motycka K, Slavík K, Dyr JE, Balcarová A, Vodrázka Z.
    Neoplasma; 1981; 28(1):3-10. PubMed ID: 6895104
    [Abstract] [Full Text] [Related]

  • 4. Effect of methotrexate sorbed on modified 2-hydroxyethylmethacrylate carriers in mice of C3H strain with a solid Gardner lymphosarcoma.
    Motycka K, Slavík, kocovská A, Cihar R, Spacek P, Kubín M.
    Neoplasma; 1977; 24(3):271-6. PubMed ID: 578291
    [Abstract] [Full Text] [Related]

  • 5. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative.
    Bures L, Motycka K, Bostík J, Slavík K, Jirásek A.
    Neoplasma; 1986; 33(4):409-16. PubMed ID: 3762803
    [Abstract] [Full Text] [Related]

  • 6. Localized chemotherapy of Gardner's lymphosarcoma of C3H mice using combinations of carrier-sorbed antifolics and detoxicating tetrahydrofolates.
    Motycka K, Slavík K, Balcarová A, Spacek P, Kubín M.
    Czech Med; 1981; 4(1-2):14-24. PubMed ID: 6973453
    [Abstract] [Full Text] [Related]

  • 7. [Antitumor effect of Corynebacterium parvum].
    Mazurek C, Chalvet H, Biozzi G, Stiffel C.
    Ann Immunol (Paris); 1977; 128(1-2):161-3. PubMed ID: 576780
    [Abstract] [Full Text] [Related]

  • 8. Treatment of solid Gardner lymphosarcoma with methotrexate sorbed on 2-hydroxyethylmethacrylate polymer in combination with leukovorin.
    Motycka K, Slavík K, Balcarbová A, Cihar R, Spacek P, Kubín M.
    Neoplasma; 1978; 25(2):217-25. PubMed ID: 306074
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of free and bovine fibrinogen-bound methotrexate and dibromoaminopterin on the dissemination of solid Gardner lymphosarcoma.
    Motycka K, Dyr JE, Macáková A, Slavík K.
    Neoplasma; 1982; 29(2):197-204. PubMed ID: 6896744
    [Abstract] [Full Text] [Related]

  • 11. Distribution and pharmacokinetics of methotrexate in localized chemotherapy of solid Gardner's lymphosarcoma.
    Slavíková V, Motycka K, Slavík K, Spacek P, Cihar R, Balcarová A.
    Neoplasma; 1978; 25(2):211-6. PubMed ID: 580447
    [Abstract] [Full Text] [Related]

  • 12. [Effect of silica on the anti-tumour activity of "Corynebacterium parvum" (author's transl)].
    Mazurek C, Stiffel C, Chalvet H, Biozzi G.
    Ann Immunol (Paris); 1979; 130(6):815-26. PubMed ID: 232975
    [Abstract] [Full Text] [Related]

  • 13. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
    Mazurek C, Stiffel C, Chalvet H, Biozzi G.
    Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
    [Abstract] [Full Text] [Related]

  • 14. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
    Mazureka C, Stiffel C, Chalvet H, Biozzi G.
    C R Seances Acad Sci III; 1981 Oct 05; 293(4):225-8. PubMed ID: 6794870
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity of the Gardner lymphosarcoma for the mice of the strain C3H (H-2k). II. Alteration of the growth and dissemination of solid Gardner lymphosarcoma following immunization by an extract of the ascitic tumor.
    Motycka K, Bostík J, Bures L, Slavík K, Jirásek A.
    Neoplasma; 1986 Oct 05; 33(2):177-85. PubMed ID: 3754937
    [Abstract] [Full Text] [Related]

  • 16. [Antitumoral activity of various doses of corynebacterium parvum as a function of the age of mice].
    Stiffel C, Chalvet H, Mazurek C.
    Ann Inst Pasteur Immunol (1985); 1985 Oct 05; 136D(1):19-27. PubMed ID: 3840664
    [Abstract] [Full Text] [Related]

  • 17. Enhancement by Corynebacterium parvum of the normal and tumor tissue response to hyperthermia.
    Urano M, Overgaard M, Suit H, Dunn P, Sedlacek R.
    Cancer Res; 1978 Mar 05; 38(3):862-4. PubMed ID: 626985
    [Abstract] [Full Text] [Related]

  • 18. Changes in metabolism, food and water intake of C3H mice following transplantation of Gardner lymphosarcoma (LSG).
    Bostík J, Vybíral S, Spundová M.
    Physiol Bohemoslov; 1988 Mar 05; 37(4):325-32. PubMed ID: 2973618
    [Abstract] [Full Text] [Related]

  • 19. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
    Yuhas JM, Ullrich RL.
    Cancer Res; 1976 Jan 05; 36(1):161-6. PubMed ID: 1247995
    [Abstract] [Full Text] [Related]

  • 20. Immunotherapy of cancer with corynebacterium parvum.
    Halpern B.
    Ann Allergy; 1978 Mar 05; 40(3):155-7. PubMed ID: 637374
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.